Objective: To explore the Xihuang capsule in combination with radiotherapy clinical outcomes in patients with nasopharyngeal carcinoma. Method: From April 2012 to April 2014 in our hospital 80 patients with nasopharyngeal carcinoma were analyzed data

the patients were randomly divided into a control group method and the experimental group and the control group using a single radiation treatment

the experimental group combined with the control group on the basis of Xihuang capsule treatment were compared treatment. Result: 55% of the treatment group

the results are satisfactory

the control group (42.5%) (P<0.05). The experimental group was 82.5% higher than clinical benefit (P<0.05). two groups of patients before treatment serum T cell subsets group level

such as:indexes were CD3+

CD4+

CD8+ and CD4+/CD8+

which are not significant. The experimental group after treatment CD3+

CD4+

CD8+ and CD4+/CD8+ other indicators significantly lower than the control group (P<0.05). The adverse reactions in the experimental group was 32.5%

lower than in the control group (42.5%) (P<0.05)

ADL score in the experimental group

physical function score

mental function scores

social function scores were higher (P<0.05). Conclusion: Capsule NPC patients in radiotherapy combined with western treatment based on the desired therapeutic effect

can improve clinical outcomes and reduce the incidence of adverse reactions

should be introduced.